» Articles » PMID: 37805487

Juvenile Dermatomyositis in Afro-Caribbean Children: a Cohort Study in the French West Indies

Overview
Publisher Biomed Central
Specialty Pediatrics
Date 2023 Oct 7
PMID 37805487
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The epidemiology of Juvenile Dermatomyositis (JDM) in non-Caucasian population is poorly described. We performed a study of patients followed up in the French West Indies for JDM. We aimed to describe clinical and biological specificities during childhood.

Methods: Retrospective study covering the period from Januarys 2000-2023. Listings of patients were obtained from multiple sources, namely computerized hospital archives, registry of referent pediatricians and adult specialists in internal medicine and the French National Registry for rare diseases. JDM and organ involvement were defined according to the international ILAR criteria.

Results: Twenty-one patients were included over a 23 year-period. Median age at onset was 8.1 years (Range: 2.5-13.9) with a median follow up of 8 years (Range: 2-19). Two-thirds (14/21) had dysphagia at onset and 33% had respiratory involvement. Thirteen had specific autoantibodies (58%), most frequently anti-Mi-2. The median number of flares during childhood was three (1-9). During childhood, 76% had calcinosis lesions. Clinical evolution seemed to be more aggressive for boys than girls (respectively 4.2 versus 2.2 flares (p = 0.04) and 50% vs 18% needing more than one background therapy, p = 0.03).

Conclusion: This retrospective study is the largest cohort of pediatric patients of Afro-Caribbean and Black African descent treated for JDM in a high-income health system, and the first to describe the incidence and immunological profile in a population of African descent. They had higher rate of calcinosis and similar respiratory involvement. Overall outcomes during childhood were similar to North America and European countries.

Citing Articles

Longitudinal follow-up of mixed connective tissue disease and overlapping autoimmune diseases of childhood onset in the Afro-descendant population of the French West Indies.

Felix A, Osei L, Delion F, Suzon B, Abel A, Drame M Pediatr Rheumatol Online J. 2024; 22(1):13.

PMID: 38212775 PMC: 10785358. DOI: 10.1186/s12969-023-00951-3.

References
1.
Guseinova D, Consolaro A, Trail L, Ferrari C, Pistorio A, Ruperto N . Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis. Clin Exp Rheumatol. 2011; 29(1):117-24. View

2.
Faller G, Mistry B, Tikly M . Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional study. Pediatr Rheumatol Online J. 2014; 12:2. PMC: 3896965. DOI: 10.1186/1546-0096-12-2. View

3.
Robinson A, Hoeltzel M, Wahezi D, Becker M, Kessler E, Schmeling H . Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry. Arthritis Care Res (Hoboken). 2013; 66(3):404-10. PMC: 4078654. DOI: 10.1002/acr.22142. View

4.
Okongo L, Esser M, Wilmshurst J, Scott C . Characteristics and outcome of children with juvenile dermatomyositis in Cape Town: a cross-sectional study. Pediatr Rheumatol Online J. 2016; 14(1):60. PMC: 5106783. DOI: 10.1186/s12969-016-0118-0. View

5.
Chipeta J, Njobvu P, Wa-Somwe S, Chintu C, McGill P, Bucala R . Clinical patterns of juvenile idiopathic arthritis in Zambia. Pediatr Rheumatol Online J. 2013; 11(1):33. PMC: 3848636. DOI: 10.1186/1546-0096-11-33. View